We used a convenient quantitative dot blot assay to measure transcript levels for two X chromosomelinked genes, myo-2 and act4, in the nematode Caenorhabditis elegans. We show that there is dosage compensation of transcript levels for these two genes between XX herm.aphrodites and XO males and that a mutation in the dpy-21 gene, postulated from genetic analysis to be involved in control of X chromosome expression, can affect these transcript levels in the manner predicted. However, we observe the dpy-21 effects only at some stages of the life cycle and not at others. These results are generally consistent with earlier genetic and molecular evidence.
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In many animals one sex has two X chromosomes and the other sex only one. Despite this 2-fold difference in X chromosome dosage, most X-linked mutations cause similar mutant phenotypes in both sexes (1) , and both sexes show equivalent levels of activities for many enzymes encoded by X-linked genes (2, 3) . The mechanism of X chromosome dosage compensation responsible for this equivalence varies among different organisms. In mammals, it is accomplished by inactivation of one of the two X chromosomes in females during most of the life cycle (reviewed in ref. 2) . In the fruit fly Drosophila, both X chromosomes are expressed in XX females, and compensation occurs by hyperactivation (relative to the autosomes) of the single X in XY males (reviewed in ref. 3) .
The nematode Caenorhabditis elegans has two sexes: self-fertilizing hermaphrodites, which have two X chromosomes (XX), and males, which have one X chromosome (X0). There is no Y chromosome; the primary signal for sex determination is the X/A ratio, the ratio of X chromosomes to sets of autosomes (4) . Early evidence for dosage compensation in C. elegans was genetic, based on analysis of hypomorphic mutations in X-linked genes. These are mutations causing partial loss of function such that the resulting phenotype varies with the level of the mutant gene product. Hypomorphic mutations of X-linked genes in C. elegans are observed to cause similar phenotypes in XX and X0 animals, indicating similar levels of the corresponding gene products, and thereby providing evidence for some mechanism of compensation for the difference in X chromosome dosage (5, 6) .
To achieve dosage compensation, the level of X chromosome expression must presumably be dictated by the X/A ratio, but the genetic basis for this regulation is still unclear. At least four autosomal and two X-linked loci have been identified as possible-regulators of X chromosome expression. The phenotypes resulting from mutations in these genes are dependent on the X/A ratio in the mutant animal (7) . These mutations result in the short phenotype known as dumpy (Dpy) . Such X/A-dependent dpy genes can be grouped into two classes. Genes in the first class, all autosomal, are dpy-21 V (7), dpy-26 IV (7), dpy-27III (8), and dpy-28 III (9) . Recessive mutations in dpy-21 and dpy-26 cause an increase in X expression based on the observation that they suppress the phenotypes resulting from hypomorphic alleles of several X-linked genes (5, 6) . A second class may be represented by the X-linked gene dpy-22 (7) , in which a recessive mutation appears to cause a decrease in X expression, enhancing the phenotypes resulting from hypomorphic alleles of several X-linked genes (5, 6) .
In order to investigate dosage compensation at the molecular level, we developed a highly reproducible quantitative RNA dot blot assay using gene-specific probes for X-linked and autosomal genes, which allowed us to compare levels of X chromosome transcripts normalized to levels of autosomal transcripts. Preliminary results suggested that for at least two X-linked genes, myo-2 [one of two pharyngeal myosin heavychain genes (10, 11) ] and act-4 [one of four actin genes (11, 12) ], dosage compensation is accomplished by regulating transcript levels, which appeared similar in XX and XO wild-type animals and elevated in a dpy-21 mutant (5). While this work was in progress, Meyer and Casson (9) reported measurements of transcript levels for myo-2 and three other, unidentified X-linked genes, based on quantitation of RNA gel blots. They showed that whereas one of the unidentified transcripts was not compensated, myo-2 and the two other transcripts were compensated and were present at increased levels in a dpy-21 mutant (9). Here we present additional results, obtained with the RNA dot blot assay, that confirm dosage compensation of myo-2 transcript levels and indicate that act-4 is similarly regulated. We also show that levels of these transcripts are affected substantially by a dpy-21 mutation and marginally by a dpy-22 mutation, in the manner expected from genetic analysis, but that the magnitude of these effects varies with the transcript assayed and with stage in the life cycle.
MATERIALS AND METHODS
Strains, Genes, and Alleles. The wild type of C. elegans var. Bristol, designated N2, as well as strains carrying the mutant alleles him-S(el490) V, dpy-21(e428) V, and dpy-22(e652) X were originally obtained from the Cambridge, England, strain collection (13) . A strain carrying the large X chromosome duplication mnDpJO(X:I) (14) was obtained from B. Meyer ( 
Massachusetts Institute of Technology).
Culturing of Nematodes. Routine methods of culturing nematodes at 20°C were employed (13) . Embryos (about 2-100 cells) were prepared by alkaline hypochlorite treatment of gravid adults (15) .
Synchronously staged animals were obtained by two different techniques. First-larval-stage animals were collected by Abbreviations: X/A ratio, X chromosome/autosome ratio.
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allowing a synchronous population of embryos isolated from young adult hermaphrodites to hatch for 9-10 hr at 160C, either in sterile M9 salts medium, aerated by shaking, or on sterile NGM plates (13) . The first-stage larvae were washed through a 20-Am Nytex mesh filter to separate them from unhatched eggs, which are retained, and then were collected by brief centrifugation in a clinical centrifuge at 4TC. Alternatively, dauer larvae were obtained by plating 10 ,ul of packed worm eggs onto chicken-egg plates (13) , which were then incubated at 200C for 7-10 days in a loosely covered, humidified plastic box. Surviving animals other than dauer larvae were eliminated by NaDodSO4 treatment (16) . Synchronous populations of young adults were obtained by feeding a population of dauer larvae at 20TC until they became young adults (24-36 hr). Adult her, maphrodites were collected at a stage when more than 50o of the animals contained no eggs and none were observed to contain more than five eggs.
Males were obtained from a mutant strain carrying the him-5(e1490) mutation, which results in a high frequency of X chromosome nondisjunction and therefore a high percentage (-30%) of male self-progeny (17) . Enriched (12) . pCeA4 will hybridize to all four actin genes, which have essentially identical coding regions. The other two probes are gene-specific (18) . pCeA103, specific for act-i, carries 135 bp of the 3' end ofthe act-i gene cloned into pUC9. pCeA403-1, specific for act-4, carries 183 bp of the 3' end of the act-4 gene cloned into pUC8.
C. elegans has four myosin heavy-chain genes (19) . Genespecific probes for three different myosin genes were used in this study. The probe for the autosomal unc-54 I myosin gene (YRp17-unc) is a 3800-bp Bgl II fragment of the unc-54 coding sequence cloned into YRp17 and was a gift from J. Shaw (University of Minnesota, St. Paul). The probe for the autosomal myo-J gene, pGBB1.6, is a 1600-bp HindIll fragment of the myo-J coding sequence cloned into pBR322.
The X-linked myo-2 clone, pGBA2.2, is a 2200-bp HindIII fragment of the myo-2 coding sequence cloned into pBR322.
The myo-) and myo-2 clones were gifts from G. Benian (Washington University Medical School, St. Louis).
Nucleic Acid Isolation. C. elegans DNA was isolated by NaDodSO4/proteinase K digestion followed by phenol/chloroform extraction (15) . RNA was isolated by centrifugation through CsCl gradients of a nematode lysate prepared in the presence of guanidine hydrochloride (20) .
DNA Gel Blots and Hybridization Conditions. DNA from wild-type first-larval-stage worms was isolated, digested with the desired restriction endonuclease, and electrophoretically fractionated in a 0.8% agarose gel. The separated DNA fragments were transferred to nitrocellulose filters (21) , which were hybridized in a solution containing 50% (vol/vol) formamide (Eastman Spectrograde), 0.10 M sodium phosphate (pHI 7.0), 3x SET (1x is 150 mM NaCl/1 mM EDTA/50 mM Tris, pH 7.8), 0.1% (wt/vol) NaDodSO4, 200 ,ug of sonicated salmon sperm DNA per ml, and 0.1 ,ug of the desired probe, labeled by nick-translation with [ca-32P]dTTP to a specific activity of 108 cpm/,ug (22, 23) . The probe was denatured by boiling for 5 min before addition to the hybridization solution. Hybridization was carried out for 18 hr at 370C for act-i and act-4 and at 50'C for unc-54, myo-i, and myo-2. These conditions are sufficiently stringent to allow only gene-specific hybridization of DNA to RNA. After hybridization the filter was washed in four changes of the hybridization buffer for 30 min each at the desired temperature followed by two 30-min washes in 2x SET buffer at the same temperature. The filter was then air-dried and exposed to x-ray film (Kodak XAR) at -70'C.
RNA (instead of the usual 16-24 hr) to ensure complete hybridization. The probes for unc-54, myo-J, and myo-2 were allowed 16 hr of hybridization at 50'C. After hybridization the filter was washed in the same manner as a DNA gel blot filter except that SSC was used instead of SET. Filters were dried and exposed to x-ray film. The dots were then cut out and placed in Liquifluor or Aquasol-2 (New England Nuclear) for radioactivity measurement in a Beckman LS8100 scintillation counter.
Format of RNA Dot Blot Experiments and Estimation of Experimental Error. In a typical experiment, 40 samples (0.5 ptg) of each of two RNAs to be compared were dotted onto nitrocellulose along with 20 blank samples (including all reagents except the RNA). The filter was then cut into halves, each with 20 samples of RNA and 10 blanks. Half-filters for each of the two RNAs were hybridized together in the same bag with a labeled probe specific for the X-linked gene to be tested. The other halves of the two filters were hybridized together with a labeled probe specific for the autosomal gene to be used as a reference. The dots were cut out and the radioactivity of each was determined in the scintillation counter. All samples were counted long enough to bring the counting error below ±2%. The mean cpm of the 10 blank dots was determined and subtracted from the cpm of each of the 20 RNA dots on that filter. The levels of radioactivity measured per dot (after blank subtraction of 40-2500 cpm) ranged from 140 to 14,000 cpm, which was 2-10 times the blank value. After blank subtraction, the mean cpm and the standard deviation of the mean were calculated for the 20 RNA dots on each filter. In subsequent calculations of ratios, experimental errors were propagated through the computations according to standard methods (25) . Values shown in the tables are weighted averages of results from two or more independent determinations. Uncertainties are expressed as one standard deviation of the mean.
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RESULTS
The control of transcript levels was investigated for two X-linked genes, act-4 and myo-2, by the quantitative RNA dot blot assay described in Materials and Methods. To correct for differences between experiments in recovery of RNA and efficiency of hybridization, levels of each X-linked transcript were normalized to levels of transcripts for one of three autosomal genes: act-i V, another actin gene (12); unc-54 I, one of the two body-wall-muscle myosin heavychain genes (26); and myo-J I, the other pharyngeal myosin heavy-chain gene (10) . All the X-linked and autosomal gene probes used were shown to be gene-specific by hybridization to DNA or RNA blots. An example is shown in Fig. la, which demonstrates the gene-specificity of the unc-54 myosin probe. 32P-ldbeled unc-54 probe, incubated with a blot of gel-fractionated EcoRI digest of wild-type (N2) DNA, hybridizes to only one fragment of 7.2 kbp and not to fragments including sequences from other myosin heavy-chain genes. All experiments were performed at or above the stringency required to achieve gene-specific hybridization (see Materials and Methods) in RNA-DNA hybridizations.
Evidence that act-4 and myo-2 genes are X-linked has been obtained by in situ hybridization of corresponding probes to chromosome squashes (11, 27) . X chromosome linkage of both genes was confirmed by quantitative DNA gel blot analysis, as shown in Fig. lb for act-4. 32P-labeled pCeA4 DNA was hybridized to a blot of gel-fractionated EcoRIdigested DNAs from N2 hermaphrodites (1) and him-5(e1490) males (d). pCeA4 hybridizes to DNA fragments representing each of the four actin genes (designated 1-4), which were identified in similar experiments using genespecific probes (18) . The act-i, act-2, and act-3 bands show a b * -72 equal intensity in both lanes, whereas the act-4 band is less intense in the male lane. Individual bands were cut out and their radioactivities were quantitated by scintillation counting. The level of radioactivity in the act-4 band relative to the act-3 band was approximately twice as high in hermaphrodites (XX) as in males [XO (Fig. lb)] , as expected for an X-linked DNA sequence.
Linearity and Reproducibility of the RNA Dot Blot Assay. Fig. 2 illustrates the reproducibility ofthe RNA dot blot assay and shows that the linear range (in which cpm of bound probe are directly proportional to the amount of RNA dotted on the filter) extends from 0 to at least 1 pug. Beyond this point the dot size (determined by the manifold used) appears to become limiting for the amount of RNA that can bind to the filter (probe was always in excess; data not shown). As shown for a typical sample in Fig. 2 , there is very little scatter in the data. Each data set is separated from the next by at least two standard deviations. For each RNA preparation used in these experiments the linear range was verified to extend from 0 to 1 tug. Generally, measurements were made with 0.5 ,ug of RNA.
Dosage Compensation of myo-2 and act4 in Males and Hermaphrodites. To determine if C. elegans shows dosage compensation of transcript levels for the myo-2 X gene, amounts of myo-2 transcripts relative to myo-1 I transcripts as the autosomal reference were measured using the dot blot assay and compared in adult males and hermaphrodites. This gene pair should be optimally suited for hermaphrodite/male comparisons because both myosins are made in the pharynx, which is not a sexually dimorphic structure.
The format of RNA dot blot assays and estimation of experimental error are described in Materials and Methods. A filter carrying multiple dots of hermaphrodite RNA and another carrying dots of male RNA were hybridized with the labeled myo-2-specific probe (pGBA 2.2). Duplicates of these two filters were hybridized with the labeled probe specific for myo-J (pGBB1.6). Normalized levels of myo-2 transcripts in the two RNA samples were calculated as the ratio of mean I .5 . 25 .1 cpm hybridized per dot for the myo-2 probe to mean cpm hybridized for the autosomal reference probe. The normalized values were compared as a hermaphrodite/male ratio (Table 1) .
If C. elegans compensates precisely at the transcript level for the difference in myo-2 gene dosage between males and hermaphrodites, then the ratio of normalized myo-2 transcripts in hermaphrodites to normalized myo-2 in males should be 1.0, which is the ratio observed (Table 1) . Therefore, C. elegans males and hermaphrodites have approximately the same steady-state levels of myo-2 transcripts and must compensate for the 2-fold difference in X chromosome dosage by regulating transcript levels.
Similar experiments were carried out to determine relative transcript levels for act-4 X, normalized to unc-54 I and act-] V. The normalized level of act-4 transcripts for hermaphrodites divided by the normalized level for males gave a ratio of about 1.1 when normalizing to unc-54 and 1.0 when normalizing to act-i (Table 1) , in good agreement with the results for myo-2 transcripts.
The observed compensation of myo-2 and act-4 transcripts could represent general X chromosome dosage compensation or could result from autoregulation by different gene-specific mechanisms. This possibility was tested for myo-2 by asking whether the level of myo-2 transcripts is sensitive to gene dosage, using hermaphrodites that carry a partial X chromosome duplication including the myo-2 locus. Genetic experiments indicate that for normally compensated X-linked genes in XX hermaphrodites, addition of one more copy in the form of a third X chromosome, producing a 2A;3X hermaphrodite, results in increased gene expression (i.e., expression is not dosage-compensated; refs 5 and 6). If myo-2 is autoregulated, then the level of myo-2 transcripts might be expected to be independent of myo-2 gene dosage; if not, then addition of a third gene copy should increase the transcript level. The partial X duplication mnDpiO includes the myo-2 gene, based on quantitative DNA gel blot experiments like that illustrated in Fig. 1 (data not shown) . By the RNA dot blot assay, the normalized level of myo-2 X transcripts in hermaphrodites carrying two copies of mnDpJO was observed to be about twice the normalized level in wild-type hermaphrodites ( Table 1) , suggesting that the myo-2 gene is not autoregulated. A comparable experiment for act-4 was not carried out because there is at present no known X duplication that includes the act-4 locus. As shown in Table 1 , the presence ofmnDplO does not increase the level of act-4 transcripts.
Effects of a dpy-21 Mutation on myo-2 and act-4 Expression. From the genetic analysis of X-linked hypomorphic mutations discussed in the Introduction, a recessive mutation in dpy-21, which results in increased expression of X-linked genes (5, 6), might be expected to cause elevated levels of X-linked gene transcripts. To test this expectation for myo-2 and act-4, RNA was isolated from wild-type and dpy-21 animals as mixed-stage populations, embryos, synchronized first-stage larvae, and synchronized young adults containing few if any embryos. Normalized levels of myo-2 and act-4 transcripts from each of these preparations were determined by the dot blot assay and compared. The results ( show that the dpy-21 mutation causes increases in the transcript levels of both X-linked genes, but to different degrees at different stages in the life cycle. For myo-2 transcript levels, the dpy-21 mutation causes a substantial increase in mixed populations and embryos but no apparent effect in first-stage larvae or young adult animals. For act-4 transcript levels, the dpy-21 mutation causes an increase in young adults, but again not in first-stage larvae.
To determine whether the lack of an effect on myo-2 transcript levels in first-stage larvae could be related to the method used to obtain these larvae, which involves hatching embryos in the absence of food so that the animals become starved, the experiment was repeated using animals hatched in the presence of bacteria and harvested before the firststage/second-stage larval molt. Again, no increase resulting from the dpy-21 mutation was seen; instead normalized myo-2 transcript levels appeared to be marginally decreased (0.87 ± 0.08 times N2 levels).
Effects of a dpy-22 Mutation on myo-2 and act4 Expression. The recessive mutation in dpy-22 would be expected to cause decreased levels of X-linked-gene expression, based on the genetic analyses discussed in the Introduction (5, 6 ). This expectation was tested in experiments similar to those described in the preceding section, using RNA preparations from wild-type and dpy-22 synchronized populations of first-larval-stage and adult animals. As shown in Table 3 , the dpy-22 mutation appears to have little effect on either myo-2 or act-4 transcript levels at the stages examined, except for a marginal but statistically significant decrease of act-4 transcript levels in both first-stage larvae and adults. DISCUSSION These studies were initiated to address two questions: (i) does C. elegans compensate for the difference in X chromosome dosage between males and hermaphrodites by regulating transcript levels of X-linked genes, and (it) do mutations in the genes dpy-21 and dpy-22, postulated to be involved in the dosage-compensation process (5) (6) (7) 9) , affect transcript levels of X-linked genes in the manner predicted by genetic analysis? With regard to the first question, our results confirm, by a somewhat different assay, the recent report of Meyer and Casson (9) that adult XX hermaphrodites and XO males have the same levels of myo-2 X transcripts relative to autosomal reference transcripts. In addition we present Qualitatively, our results are consistent with the genetic analyses. In mixed-stage hermaphrodite populations, which include embryos, all larval stages, and adults, the dpy-21 mutation results in a 1.8-fold increase in myo-2 transcript levels. In embryos, the effect is smaller (1.4-fold), and in young adults (containing few if any embryos) and in firststage larvae, no effect is seen. Therefore, the magnitude of the dpy-21 effect on myo-2 transcripts differs markedly at different stages in the life cycle. The finding that mixed populations show a larger effect than either embryos, firststage larvae, or young adults suggests that a large effect would also be seen during later larval development, but synchronized populations at these stages were not tested.
Effects on act-4 transcript levels show a somewhat different pattern, but again exhibit variation between the two stages tested. An effect of about 1.5-fold is seen in young adults, and no significant effect is seen in first-stage larvae.
These findings are consistent with the possibility that in order for an effect to be seen, both dpy-21 and the X-linked gene in question have to be active, and that these genes are not all active at all stages. Such an interpretation would be particularly plausible if X transcript levels are controlled by regulation of transcription rates. From the genetic evidence, dpy-21 is presumably active during the stages when let-2 and lin-15 are active-that is, in late embryos and later larval stages (5, 6) . There is some evidence that dpy-21 is active in first-larval-stage animals (9) . The act-4 gene, suspected to code for cytoplasmic actin, may be expressed throughout the life cycle (18) . The pattern of expression of the myo-2 gene is not known at the RNA level or the protein level, except that the pharyngeal myosin heavy chains are in greatest abundance relative to those ofthe body-wall-muscle myosins early in development (30) .
The above interpretation would also explain an apparent discrepancy between one of our results and that of a similar experiment reported by Meyer and Casson (9) , who observed a substantial effect of a dpy-21 mutation on myo-2 transcript levels in adult hermaphrodites. Because the synchronized young adults used in our experiments contained few if any late-stage embryos, whereas the adults used by Meyer and Casson could have been somewhat older, gravid animals, the discrepancy could be explained if myo-2 and dpy-21 are much more active in late embryos than in adults, consistent with our results in Table 2 .
The only-marginal effect of the dpy-22 mutation on act-4 transcript levels and the lack of effect on myo-2 transcript levels seemed somewhat surprising in view of the finding that this mutation causes strong enhancement of phenotypes resulting from X-linked hypomorphic mutations, suggesting a substantial decrease in X expression (5, 6) . This discrepancy could reflect gene-specific differences in response to the dpy-22 defect or simply reflect again, as pointed out above, that the quantitative relationship between level of gene expression and severity of a complex mutant phenotype is unpredictable-that is, a small change in mRNA levels can quite possibly have a large phenotypic effect.
In summary, our results support the general conclusions that C. elegans compensates for the difference in X chromosome dose between XX and XO animals by regulating levels of X-linked gene transcripts and that a dpy-21 mutation causes increases in these transcript levels at some stages of the life cycle but not others. Our tentative interpretation of the dpy-21 effects can be tested by further investigation of these and additional genes using RNA from appropriately staged animals.
